Proactive investorsLogo Proactive Investors UK Website

Search field
Get Adobe Flash Player Download
Flash
Player ►

And
Enable
Javascript

1 year chart

digital-look imported chart image

1 day chart

digital-look imported chart image
Additional information
Additional Information
Market: AIM, ASX
Sector: Gold Mining
Epic: AGLD
News: Latest news
Web Site: Allied Gold
Other Articles: 21-01-201027-11-200916-11-2009

RSS - Subscribe to the News Today on Proactive UK ▼

Tuesday March 16, 11:29Mercator Gold to sell exclusive Copper Flat option to Canada's THEMAC Resources

The deal will allow the group to retain a substantial interest in the promising Mexican copper-gold-molybdenum-silver project without the associated costs.

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive NA ▼

Monday March 15, 11:38Calvin Klein owner buys Tommy Hilfiger for US$3 billion from Apax Partners

The New York listed shirt and neckwear company is paying €1.924 billion in cash and issuing €276 million in PVH common stock (approximately 8.7 million shares) to fund the transaction.

 

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive CN ▼

Monday March 15, 08:01China's growth boosting commodity prices

The latest economic figures from China have put pressure on the dollar and boosted a number of high-yielding currencies, including the Australian dollar and the South African rand.

FULL ARTICLE ►
Allied Gold

Allied Gold

Allied Gold Limited (ASX: ALD; AIM:AGLD) is an Australian-based company with gold production and exploration activities in Papua New Guinea.  Its gold producing Simberi mine site is located in the Tabar Islands, with exploration for gold and other mineral resources such as copper taking place on the adjacent Tatau and Big Tabar Islands. 

In 2008-09, the company produced 80,000 ounces of gold, with gold production to increase to an estimated 100,000 ounces for the fiscal year 2009-10.  Allied Gold intends to ramp up total gold production to a further 200,000 ounces by 2013.

 

Friday, November 27, 2009

Allied Gold receives high-grade gold assays at Pigiput and Pigibo gold prospects

company news image

Australian-listed Allied Gold (ASX: ALD) has received further high-grade gold assays from diamond core and reverse circulation holes drilled at the Pigiput and Pigibo gold prospects in Papua New Guinea.

The latest drilling and assay results continue to affirm the continuity of gold grade and width of mineralisation at both the Pigiput and Pigibo prospects.

The best down-hole intercepts in diamond core holes included 119m @ 2.15g/t Au from 158m in SU, 35m @ 1.65g/t Au from 211m in SU, 49m @ 2.88g/t Au from 129m in SU and 6m @ 5.11g/t Au from 136m in SU.

Gold assays were received for samples from fourteen 14 diamond core holes, drilled at the Pigiput Deposit as part of an ongoing in-fill and step-out program. The holes are part of a drilling programme, commenced in May 2009, designed to support the A$10 million Sulphide and Oxide Expansion Studies.

These studies target increasing total oxide and sulphide production to in excess of 200,000oz p.a. by 2012.

Gold assays received from two diamond core and six reverse circulation holes, defined the down dip extension of the Pigibo deposit.

Mineralised down-hole intercepts were found in 3 holes including 28m @ 3.82g/t Au from 108m in OX, TR, SU, 42m @ 3.64g/t Au from 37m in TR and 42m @ 2.82g/t Au from 78m in TR, SU.

The company is actively undertaking in-fill and step-out reverse circulation and diamond core drilling at two prospect areas, Pigiput and Pigibo, centred 800 metres apart in the central part of mining lease ML136.

Allied Gold Limited’s gold production and exploration development portfolio is centred on the Tabar Islands of Papua New Guinea, approximately 60 kilometres from Lihir Island which hosts a plus 40 million ounce gold resource and is well placed in the Pacific Rim of Fire.

AddThis Feed Button
Register here to be notified of Proactiveinvestors One2One Forums.

Investors interested in Allied Gold recently viewed


No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.